Laminin-γ2–NR6A1 Fusion Protein Promotes Metastatic Potential in Non–Small-Cell Lung Carcinoma Cells without Epidermal Growth Factor Receptor Mutation
Open Access
- 17 April 2025
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 195 (7) , 1328-1339
Abstract
No abstract availableKeywords
Funding Information
- Princess Takamatsu Cancer Research Fund
- Japan Agency for Medical Research and Development (JP24fk0210101)
- Japan Agency for Medical Research and Development (JP24ama221414)
This publication has 47 references indexed in Scilit:
- Expression of the laminin genes family and its relationship to prognosis in pancreatic carcinomaArab Journal of Gastroenterology, 2024
- LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathwayJournal of Cancer Research and Clinical Oncology, 2024
- Cancer driver mutations: predictions and realityTrends in Molecular Medicine, 2023
- Serum Laminin γ2 Monomer as a Diagnostic and Predictive Biomarker for Hepatocellular CarcinomaHepatology, 2021
- Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of ALK-Rearranged Lung CancerJournal of Thoracic Oncology, 2020
- Laminin 332 in cancer: When the extracellular matrix turns signals from cell anchorage to cell movementSeminars in Cancer Biology, 2020
- LAMC2 enhances the metastatic potential of lung adenocarcinomaCell Death & Differentiation, 2015
- RET, ROS1 and ALK fusions in lung cancerNature Medicine, 2012
- Epidermal growth factor receptor mutations in lung cancerNature Reviews Cancer, 2007
- Matrix metalloproteinases process the laminin-5 γ2-chain and regulate epithelial cell migrationBiochemical and Biophysical Research Communications, 2003